Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proviant Technologies was a specialty pharmaceutical company based in Malvern, Pennsylvania, that specialized in the development of innovative transdermal drug delivery systems. The company utilized a proprietary technology platform to create patch-based formulations of existing medications, aiming to improve therapeutic outcomes and patient adherence. In December 2006, Proviant was acquired by Mylan (now part of Viatris) for approximately $11 million in an effort to expand Mylan's internal R&D capabilities in the transdermal space. Following the acquisition, Proviant's technologies and pipeline were integrated into Mylan's broader portfolio, contributing to their offerings in pain management and central nervous system therapies. The company's expertise was central to Mylan's strategy of becoming a leader in the generic and specialty transdermal market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proviant Technologies.